DREAM: a database of experimentally supported protein-coding RNAs and drug associations in human cancer

Shupeng Li1, Lulu Li1, Xiangqi Meng1

  • 1Department of Neurosurgery, the Second Affiliated Hospital of Harbin Medical University, Neuroscience Institute, Heilongjiang Academy of Medical Sciences, Harbin, 150086, China.

Molecular Cancer
|November 14, 2021
PubMed

Insights

The DREAM database compiles experimentally validated associations between protein-coding RNAs and drug responses in human cancers. This resource aids researchers in understanding RNA

Area of Science:

  • Genomics and Bioinformatics
  • Cancer Therapeutics
  • Molecular Biology

Background:

  • The Drug Response Gene Expression Associated Map (DREAM) is a manually curated database.
  • It documents experimentally supported associations between protein-coding RNAs and drugs in human cancers.
  • The current version integrates 3048 literature-supported entries and 195 high-throughput microarray datasets.

Discussion:

  • DREAM provides detailed information on protein-coding RNA, drugs, and cancer types.
  • It includes data from PubMed and the Gene Expression Omnibus (GEO) databases.
  • The database facilitates understanding of drug sensitivity and intervention-related RNAs.

Key Insights:

  • Each entry links specific protein-coding RNAs to drug responses in various cancers.
  • The database supports research into personalized cancer treatment strategies.
  • It highlights the role of specific RNAs in modulating drug efficacy.

Outlook:

  • DREAM offers data visualization and online analysis tools, including volcano plots and enrichment analyses.
  • It aims to support novel drug discovery and development.
  • The database serves as a valuable resource for both clinical practice and fundamental cancer research.